1. Introduction {#sec1}
===============

*Fasciolosis* is a parasitic disease, caused by *Fasciola hepatica* (*F. hepatica*) and *Fasciola gigantica* (*F. gigantica*), leading to substantial financial losses and affecting human health ([@bib56]). It is estimated that 2.4--7 million people are infected and 90 million people are at risk ([@bib20]). More than 700 million domestic animals are at risk worldwide, with economic losses exceeding US\$ 2 billion per year ([@bib47]). *Fasciolosis* is geographically widely dispersed in Africa, Asia, Europe, the Americas and Oceania, as well as other temperate countries and regions ([@bib24]; [@bib27]). In China, it is prevalent throughout the north to Heilongjiang Province, south to Yunnan and Guangdong Provinces, east to Jiangsu and Taiwan Provinces, and west to Gansu and Xinjiang Provinces ([@bib55]). Approximately 28.5% of sheep were infected by *F. hepatica* in Heilongjiang Province from 1999 to 2003 ([@bib51]). The prevalence of *F. hepatica and F. gigantica* in buffaloes in Hunan Province was 44.7% and 24.9%, respectively ([@bib23]). Gansu Province has a prevalence *F. hepatica* ranging from 21.8% to 39.1% in yaks ([@bib58]). The cattle in Haikou have a seropositive rate of 19.92% ([@bib52], in Chinese). Moreover, fascioliasis outbreaks caused by *F. gigantica* have been reported in Yunnan ([@bib7]).

Guangxi Zhuang Autonomous Region is located in the southern part of China ([@bib46]), and has one of the largest buffalo populations in China. Both *F. hepatica and F. gigantica* infection are frequently found in buffaloes in Guangxi Province; the serum positive rate of buffaloes infected with *F. gigantica* in suburbs of Qinzhou city in Guangxi was 38.57% ([@bib19], in Chinese). Indirect ELISA showed that the seropositive rates of buffaloes infected with *Fasciola* in most areas in Guangxi were between 60% and 80% ([@bib36], in Chinese). These reports were all published in Chinese journals, but the information about the prevalence of *F. hepatica* in buffaloes is limited. The objective of the present study was to investigate the prevalence of *F. hepatica* infection in Guangxi Province and provide baseline information for estimating the effectiveness of control and treatment strategies against *F. hepatica* infection in buffaloes in Guangxi.

Currently, the control of fasciolosis in animals relies on the use of anthelmintic drugs, such as albendazole, rafoxanide, and triclabendazole. Triclabendazole is commonly used to treat fascioliasis in China ([@bib57]; [@bib52]; [@bib16]; [@bib59]; [@bib22]; [@bib50]; in Chinese). Oxyclozanide is also widely used to treat infections caused by *F. gigantica* and *F. hepatica* as well as other intestinal trematodes and gastrointestinal nematodes ([@bib1]; [@bib2]; [@bib17]; [@bib34], [@bib35]; [@bib40]; [@bib44]); however, oxyclozanide has never been used in China. The present study also evaluated the efficacy of triclabendazole and oxyclozanide against *F. hepatica* in naturally infected buffaloes.

2. Materials and methods {#sec2}
========================

2.1. Site location and sample collection for the prevalence study {#sec2.1}
-----------------------------------------------------------------

*F. hepatica* infection is determined in epidemiological surveys via faecal egg detection. A total of 767 individual faecal samples for *F. hepatica* egg detection testing were collected from the rectums of randomly selected buffaloes on 58 farms from Wuzhou, Liuzhou, Yizhou, Jiangzhou, Yulin, Baise, Guilin and Chongzuo in Guangxi Zhuang Autonomous Region. The samples were stored at 4 °C in self-sealing polyethylene bags labelled with the management number of each buffalo. The presence of *F. hepatica* eggs in the faeces was determined using a modified sedimentation technique ([@bib2]; [@bib28]).

All experimental methods, animal care and the barn environment in this study were in strict accordance with the Guide for the Care and Use of Laboratory Animals, Lanzhou Institute of Husbandry and Pharmaceutical Sciences, China. All efforts were made to minimize suffering.

2.2. Evaluation of drug efficacy {#sec2.2}
--------------------------------

In a preliminary experiment aiming to determine the optimal dosage of oxyclozanide, a dose confirmation test of oxyclozanide was performed before the anthelmintics efficacy test. Sixty buffaloes infected with *F. hepatica* were randomly divided into 4 groups, with 15 buffaloes in each group, and treated with oxyclozanide at 5 mg/kg, 10 mg/kg, 20 mg/kg or without treated as control, respectively. Accordingly, the optimate dosage of oxyclozanide is 10 mg/kg.bw ([Table S1](#appsec1){ref-type="sec"}).

Two-hundred seventy-seven buffaloes that had been naturally infected with *F. hepatica* from the above 58 farms were used to evaluate the efficacy of anti-fasciolosis drugs. The buffaloes were of both sexes, ranged in age from 1.5 to 3 years, and weighed between 200 and 300 kg. The buffaloes examined had not been treated recently. The buffaloes were randomly divided into 3 groups ([Table 1](#tbl1){ref-type="table"}). Group 1 was administered oxyclozanide (10 mg/kg.bw, n = 101), group 2 was administered triclabendazole (12 mg/kg.bw, n = 94) ([@bib13]), and group 3 was untreated and considered the control group (n = 82). The animals were administered the drugs once orally, and the dose was based on live weight. All buffaloes were maintained under nearly identical conditions, and enough water and food were provided. The efficacy of anthelmintics was assessed according to the FECR, buffaloes positive by coprology reduction (BPCR) based on the values on days 21 and 28 as well as improvements in biochemical indicators and haematological parameters post-treatment.Table 1Experimental drugs, groups and doses.Table 1GroupsNumber of animalsAnthelminticsDosage (mg/kg.bw)1101Oxyclozanide10 mg/kg.bw294Triclabendazole12 mg/kg.bw382

### 2.2.1. Eggs per gram (EPG), FECR and BPCR {#sec2.2.1}

During the experimental period, clinical manifestations were observed. Individual faecal samples were examined at days 0 (before treatment), 7, 14, 21 and 28 after treatment. Eggs per gram (EPG) was ascertained using the sedimentation technique as described above. FECR for each group as calculated using three different methods described by [@bib5]: Method 1 is the technique recommended by the World Association of the Advancement of Veterinary Parasitology, which compares post-treatment arithmetic means of treated and control groups ([@bib9]); Method 2 uses means of individual animal pre- and post-treatment counts to derive individual FECR reductions ([@bib37]); Method 3 uses changes in the untreated control group means to correct for changes in FECR between collection dates using arithmetic means ([@bib12]). Buffaloes positive by coprology reduction (BPCR) is the % of animals with no eggs after treatment and were determined using the following formulas ([@bib3]; [@bib4]):$$\%\ \text{BPCR} = \left( {1 - \frac{\text{Positive}\ \text{buffaloes}\ \text{post} - \text{treatment}}{\text{Positive}\ \text{buffaloes}\ \text{pre} - \text{treatment}}} \right) \times 100$$

Positive buffaloes~pre-treatment~ is the total number of infected buffaloes before treatment. Positive buffaloes~post-treatment~ is the number of infected buffaloes after treatment. The efficacy of anthelmintics were determined based on the values on days 21 and 28 ([@bib53]), and the difference in EPG between days 21 or 28 and 0 were calculated.

### 2.2.2. Haematological and biochemical analysis {#sec2.2.2}

To evaluate the changes in haematological and biochemical parameters after drug treatment, two venous blood samples were aseptically obtained from each buffalo on day 0 (before treatment) and day 14 (post-treatment). One sample was immediately transferred into a vacutainer containing ethylenediaminetetraacetic acid (EDTA) anticoagulant and maintained at 4 °C, and the other was collected into a vacutainer without anticoagulant and centrifuged at 3000 rpm for 10 min to separate the serum. Serum samples were then frozen at −20 °C.

The whole blood samples with EDTA anticoagulant were transferred to the laboratory, and haematological studies were performed using a veterinary automatic blood cell analyser (BC-2800Vet, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, China). The following haematological parameters were measured: red blood cells (RBCs), haemoglobin (Hb), packed cell volume (PCV), white blood cells (WBCs) and eosinophils (EOS).

The concentrations of total protein (TP), albumin (A), aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), lactate dehydrogenase (LDH), glucose (GLU), and alkaline phosphatase (ALP) were measured in the serum samples using commercially available kits (Ningbo Meikang Biotechnology Co., Ltd, China) and an automatic biochemical analyser (XL-640, Erbe China Ltd, China).

2.3. Statistical analysis {#sec2.3}
-------------------------

Descriptive data are presented as means ± standard deviations (SD). Significant differences were determined using the Mann-Whitney test for variance at *P* \< 0.05 using the SPSS 13.0 Windows statistical package (2004).

3. Results {#sec3}
==========

3.1. Faecal egg detection test and prevalence study {#sec3.1}
---------------------------------------------------

The results in [Table 2](#tbl2){ref-type="table"} indicate that the districts in Guangxi were positive for *F. hepatica*, with infection rates ranging from 71.91 to 95.65%. These rates suggest that relatively high *F. hepatica* burdens are present. The total rate of infection in all 767 buffaloes was 87.35%.Table 2Prevalence of *F. hepatica* infection in each district based on the faecal egg detection.Table 2DistrictsNumber of farmsMean buffaloes/farmNumber of animals/districtAnimals positivePrevalence (%)Wuzhou811.13896471.91Liuzhou814.7511810488.14Yizhou1220.5024621185.77Jiangzhou48.25332987.88Yulin611.50696695.65Baise415.50625690.32Guilin1010.001009595.00Chongzuo68.33504590.00Total5813.2276767087.35

3.2. Flukicidal efficacy test {#sec3.2}
-----------------------------

During the flukicidal efficacy test, the clinical signs observed in the affected buffaloes were anorexia and persistent diarrhoea. The buffaloes recovered from their illness within 28 days post-treatment. There was an improvement in body weight following the administration of flukicide. [Table 3](#tbl3){ref-type="table"} shows the mean EPG in faeces of each group on each day, and EFCR% was calculated at days 21 and 28 using 3 different methods. The treatment groups showed a significant (*P* \< 0.05) reduction in EPG on days 7--28. All three methods of calculation were in agreement that the FECR% values in groups 1 and 2 were up to 98%, which indicated the good efficacy of the drugs. Furthermore, the majority of the oxyclozanide-treated buffaloes had nearly zero EPG at the end of the experiment according to the BPCR of 97.03%, whereas the BPCR% in the triclabendazole treatment group was 77.66%. The EPG for group 3 (untreated) did not show a significant change throughout the experimental period.Table 3Eggs per gram (EPG), faecal egg count reduction (FECR) and buffaloes positive by coprology reduction (BPCR).Table 3DaysEPG ± SDFECR% (day 21)FECR% (day 28)BPCR (%)Pre-treatmentPost-treatmentMethodsMethods07142128123123Group1106.21 ± 41.1942.34 ± 22.19^∗^3.33 ± 8.77^∗^1.53 ± 5.14^∗^0.28 ± 1.67^∗^98.5698.5698.5599.7399.7499.7397.03Group 2100.89 ± 45.4627.69 ± 20.91^∗^17.45 ± 17.72^∗^1.39 ± 3.04^∗^1.63 ± 3.87^∗^98.6998.6298.6198.4698.3898.3777.66Group 3106.74 ± 41.02101.69 ± 24.2396.85 ± 20.50107.14 ± 23.04106.02 ± 17.76[^1][^2][^3]

3.3. Haematological and biochemical analyses {#sec3.3}
--------------------------------------------

[Table 4](#tbl4){ref-type="table"} summarizes the haematological parameters of buffaloes in each group on days 0 and 14 post-treatment*. F. hepatica* infection in group 3 exhibited a decreasing trend in Hb, RBC, and PCV values between days 0 and 14. WBC and EOS levels were elevated in group 3 (day 14: 12.9 ± 1.8 and 0.009 ± 0.019, respectively) compared to values obtained before the experiment (day 0: 12.5 ± 1.7 and 0.006 ± 0.009, respectively). However, for the oxyclozanide and triclabendazole treatment, there were increased trends in Hb, RBC and PCV with respect to the values obtained before the experiment in groups 1 and 2, and the drug treatment also caused a decreased trend in WBC and EOS levels on day 14 compared to those on day 0, although these changes were not significant compared with those at day 0.Table 4Haematological parameters of the buffaloes on days 0 and 14 post-treatment.Table 4GroupsDayWBC (10^9^/L)EOS (10^9^/L)RBC (10^12^/L)Hb (g/L)PCV (%)1012.8 ± 2.60.009 ± 0.0115.7 ± 1.2111 ± 1534.8 ± 6.61412.5 ± 2.00.004 ± 0.005^∗^6.1 ± 1.2115 ± 1437.1 ± 5.62012.2 ± 1.10.006 ± 0.0115.8 ± 0.6115 ± 1534.1 ± 3.41412.1 ± 1.20.005 ± 0.0075.9 ± 0.7116 ± 1036.5 ± 6.23012.5 ± 1.70.006 ± 0.0095.8 ± 0.7115 ± 1133.7 ± 3.31412.9 ± 1.80.009 ± 0.0195.5 ± 0.8113 ± 1332.2 ± 5.0[^4][^5][^6]

[Table 5](#tbl5){ref-type="table"} shows the biochemical parameters of buffaloes in each group on days 0 and 14 post-treatment. Mean values for TP, A, and GLU decreased over time in group 3, while AST (*P* \< 0.05), ALT, GGT, LDH and ALP (*P* \< 0.05) values increased. Treatment with oxyclozanide or triclabendazole resulted in improvements trend in these values on day 14 of the experiment compared with the day 0 values; in particular, the concentrations of GGT were significantly decreased (*P* \< 0.05) in groups 1 and 2.Table 5Biochemical parameters of the buffaloes on days 0 and 14 post-treatment.Table 5GroupsDayTP (g/L)A (g/L)AST (U/L)ALT (U/L)GGT (U/L)LDH (U/L)GLU (mmol/L)ALP (μmol/L)1072.4 ± 8.822.9 ± 2.9207 ± 3536.0 ± 14.029.3 ± 7.5828 ± 1470.5 ± 0.3182 ± 311472.9 ± 9.223.9 ± 3.3198 ± 3834.9 ± 9.025.1 ± 7.2^∗^821 ± 1290.6 ± 0.2180 ± 452073.1 ± 15.223.5 ± 2.9198 ± 9333.9 ± 4.730.0 ± 5.0815 ± 1020.5 ± 0.2163 ± 571474.0 ± 8.625.3 ± 3.7^∗^187 ± 3432.9 ± 7.725.2 ± 5.8^∗^812 ± 810.5 ± 0.3162 ± 413074.8 ± 10.023.0 ± 3.1209 ± 3533.3 ± 7.029.6 ± 6.1835 ± 1670.5 ± 0.2161 ± 501473.6 ± 11.022.7 ± 4.3241 ± 32^∗^36.6 ± 7.631.9 ± 5.2860 ± 800.3 ± 0.1167 ± 30^∗^[^7][^8][^9]

4. Discussion {#sec4}
=============

Temperature, water and snail are important factors in the epidemicity of *F. hepatica*. At the same time, rainfall has a positive effect on the development of *F. hepatica* and reproduction of the snail intermediate host ([@bib25]; [@bib30]; [@bib39]). The present study confirmed 87.35% prevalence of *F. hepatica* infections in buffaloes on 58 farms from 8 districts in Guangxi, this is consistent with the results of *F.gigantica* in Guangxi reported by [@bib36], in Chinses). This high prevalence may be due to the favourable climate, abundance of aquatic sources and rainfall in Guangxi, which make it a good habitat for *F. hepatica*\'s intermediate snail host. Furthermore, local buffaloes are mostly raised in a free-range way, which exposes buffaloes more access to intermediate hosts ([@bib19], in Chinese). In addition, buffaloes are most susceptible to severe infections when they are reared and grazed in narrow and humid paddy fields for a long time. Domestic buffaloes can also be infected by mowing grass from low-lying wet pastures ([@bib52]. in Chinese). As buffaloes are the main labour animal, buffalo farming constitutes an important agricultural sector in Guangxi Province; buffaloes are raised and kept as economically important animals because they provide milk, meat and hides of good quality ([@bib54]). *F. hepatica* infection of buffaloes is common and may cause considerable economic losses to the buffalo industries and farming communities as a consequence of the death of infected animals and reduced weight gains ([@bib6]; [@bib8]; [@bib42]). Therefore, the high prevalence of infection indicates that control strategies must be implemented.

Effective drugs to control fasciolosis are in urgent need. According to the guidelines from the World Association for the Advancement of Veterinary Parasitology for fasciolosis diagnosis, efficacy is determined by comparing faecal egg counts from treated and untreated animals shortly before or at the time of treatment and not less than 3 weeks later ([@bib53]). Other researchers have estimated the efficacy of anthelmintics against *Fasciola* spp. at two weeks post-treatment ([@bib2]; [@bib28]; [@bib33]; [@bib44]). However, eggs can be stored in the gall bladder for several weeks, even after removal of the adult flukes. Therefore, the measurement interval must be long enough to ensure that any eggs in the gall bladder are expelled from the animals following drug treatment ([@bib2]). The efficacy of anthelmintics against *F. hepatica* was evaluated over a period of 28 days in this clinical trial.

As an uncoupling agent, the antihelminth efficacy test clearly showed that oxyclozanide has high efficacy against fascioliasis yielded a 98.55% reduction in FECR on day 21 post-treatment and up to a 99.74% reduction in FECR on day 28, this finding is consistent with the results of [@bib44]. Additionally, the positive by coprology reduction can be used to determine whether the eggs have been completely removed. The animals in the oxyclozanide treated group were close to egg-free following the maximum BPCR of 97.03%, which indicated the eggs in most buffaloes had been completely removed. This high efficacy may be due to oxyclozanide blocks oxidative phosphorylation and inhibits ATP production in the mitochondria of this parasite, causing it to die due to energy metabolism disorders ([@bib10]; [@bib38]; [@bib43]; [@bib49]). However, triclabendazole, which targets both the tissue-damaging immature stages and the mature adult stages of the parasites ([@bib11]), showed the BPCR% was 77.66% after 28 days treatment, which is lower than that in oxyclozanide treatment group. This may be due to triclabendazole treatment did not repelled all *F. hepatica* in individual buffaloes. Although the resistance to this drug has been frequently reported in other areas ([@bib14]; [@bib18]; [@bib21]; [@bib29]; [@bib31]; [@bib32]; [@bib33]; [@bib48]), our study indicated that triclabendazole is still effective against *F. hepatica* infection in Guangxi Province based on the FECR of up to 98%. Furthermore, oxyclozanide may be an alternative drug for fascioliasis in China.

In addition, *F. hepatica* parasitizes the intrahepatic bile duct, causing liver or bile duct damage, which influences the normal values of biochemical indicators and haematological parameters. In infected untreated group 3, there were minor decreases in the mean values of RBC, Hb, PCV, TP, A, and GLU. The changes in RBC, Hb and PCV may due to the secretory toxins of *F. hepatica*, which exert haemolytic effects and haemorrhage, leading to anaemia, anaemia also results from blood digestion by adult flukes. The decreases in TP and A levels are likely due to the reduced albumin synthesis and increased plasma protein leakage into the gut associated with fasciolosis. AST, GGT and ALT levels are important indicators of the degree of cholestasis and the synthetic capacity of the liver ([@bib45]). Elevated levels of the serum enzymes AST and ALT were observed in the infected buffaloes, possibly due to extensive damage to the liver parenchyma, the production of hepatotoxins and cellular necrosis. Furthermore, the marked increase in GGT level associated with cholestasis and bile duct damage. Damage to the bile duct epithelium causes the release of GGT into the circulation, which increases the GGT level in serum mainly after flukes have entered the bile duct ([@bib26]). Additionally, elevated levels of LDH and ALP, which are also indicators of damage to the liver parenchyma and bile ducts, are caused by the migration of *F. hepatica* ([@bib28]). In *F. hepatica*-infected hosts, hepatic parenchymal injury and abnormal hepatic function not only decrease the concentration of GLU but also cause an immune response in the host, leading to increased WBC, particularly in EOS ([@bib15]). However, gradual decreases in the mean values of WBC, EOS, AST, ALT, GGT, LDH and ALP were recorded along with gradual increases in the mean values of RBC, Hb, PCV, TP, A, and GLU in the oxyclozanide and triclabendazole treatment groups. These results are consistent with previous studies ([@bib41]; [@bib43]; [@bib44]; [@bib45]).The recovery of altered biochemical indicators and haematological parameters may have been due to flukicide activity of oxyclozanide and triclabendazole.

5. Conclusion {#sec5}
=============

This study has demonstrated a high prevalence in Guangxi Province of *F. hepatica*, and revealed that oxyclozanide and triclabendazole effectively restored the health of infected buffaloes and reduced the EPG of *F. hepatica* by killing the parasite. Oxyclozanide could be a useful alternative drug for *F. hepatica* infection in China.
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[^1]: The mean EPG of buffaloes from each group was counted at days 0, 7, 14, 21 and 28 after treatment. FECR% were calculated at days 21 and 28 by the three methods (Method 1 was the WAAVP method; Method 2 calculated individual buffalo reductions followed by transformation and averaging; Method 3 accounted for changes in control values over time and used group means).

[^2]: Significant differences of EPG between pre-treatment and post-treatment in each group were determined using the Mann-Whitney test.

[^3]: \* = Significant at the 5% level (*P* \< 0.05).

[^4]: The above values represent the mean ± SD of buffaloes from each group.

[^5]: Significant differences between days 0 and 14 in each group were determined.

[^6]: \* = Significant at the 5% level (*P* \< 0.05).

[^7]: The above values represent the mean ± SD of buffaloes from each group.

[^8]: Significant differences between days 0 and 14 in each group were determined.

[^9]: \* = Significant at the 5% level (*P* \< 0.05).
